Article
Red blood cell alloimmunization mitigation strategies.
Transfusion medicine reviews - 1 Jul 2014
Hendrickson Jeanne E, Tormey Christopher A, Shaz Beth H
Abstract excerpt
Hemolytic transfusion reactions due to red blood cell (RBC) alloantibodies are a leading cause of transfusion-associated death. In addition to reported deaths, RBC alloantibodies also cause significant morbidity in the form of delayed hemolytic transfusion reactions. These alloantibodies may also cause morbidity in the form of anemia, with compatible RBC units at times being unable to be located for highly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
